Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824310) titled 'Immunogenicity and Safety of HPV-4 Vaccine With or Without Td Vaccine in Children' on Sept. 11.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: PT Bio Farma
Condition:
Human Papillomavirus (HPV) Infection
Intervention:
Biological: Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: October 2026
Target Sample Size: 266
Countries of Recruitment:
Indonesia
To know more, visit ht...